Log In
BCIQ
Print this Print this
 

PF-4191834

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
Description5-lipoxygenase (ALOX5) (5-LO) inhibitor
Molecular Target 5-lipoxygenase (ALOX5) (5-LO)
Mechanism of Action5-lipoxygenase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today